As this article informs, Medelis, an oncology CRO, is providing a free downloadable abstract titled Preclinical Trials: A Nuanced Approach to Get Into the Clinic Faster. The purpose of the abstract is to provide tips specifically for Chief Medical Officers to help them and their organization get to clinic faster. As the Medelis website reports, some of the topics covered include:
- Critical factors for a CMO to understand and evaluate during this step in the drug development process
- Regulatory assessments and how to avoid hitting a preclinical wall
- The nuances and complexities of rodent models, tumor selection, and other variables
- How to keep the preclinical, regulatory and clinical teams involved in feasibility dialogue
- The typical preclinical study process and the questions a CMO should be asking at each step
- Additional requirements unique to oncology preclinical trials
- What to look for in an outside preclinical team
No comments:
Post a Comment